Eva pharma Portfolio presentation on all medicines .pptx

A presentation on Eva pharma portfolio

1. EVAPharma Portfolio Meeting unmet needs

2. How many patients served by EVA? Scientific findings 2

3. How many patients served by EVA? EVA serves 1 million patients daily through manufacturing more than 1 million doses of medication daily EVA Pharma is the second largest pharmaceutical company in Egypt and has a history of over 100 years in healthcare 3

4. Scientific findings 4 Egypt unmet medical needs and disease burden?

5. Egypt's disease burden Persistent, though diminishing, communicable diseases: Rapidly growing burden of non-communicable diseases (NCDs): infectious diseases like hepatitis and tuberculosis. Vector-borne diseases like schistosomiasis and Leishmaniasis are still present, although progress has been made in reducing their prevalence. the leading cause of death, accounting for 82% of all deaths and 67% of premature deaths with cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases being the biggest threats. Info. Provided by CDC/WHO Egypt website 5

6. What are the therapeutic areas does EVA portfolio cover ? 6

7. Cardiovascular System 8 main products (15 variants) 7

8. Cancer and Immunity 6 main products 8

9. Most Common Cancer in Egypt Breast Cancer Scientific findings 9

10. Partnership with Eli lilly Scientific findings 10

11. Diabetes and Metabolism 11

12. Dermatology 12

13. Genitourinary system 13

14. Anti - infectives 14

15. Ophtalmology 15

16. Neurology 16

17. OTC 17

18. Musculoskeletal System Scientific findings 18

19. Animal Health Scientific findings 19

20. Poultry and Chickens Scientific findings 20

21. Are Drugs the only products of EVA pharma? 21

22. Overview What are the healthcare potentials of EVA pharma ? Digital health solutions and health insurance: Serving patients with better Data Medications and Pharmaceuticals: High quality potent medicine Research centers: Clinical and preclinical 22

23. Digital Healthcare 23

24. What is EVA pharma main focus? M eeting unmet needs 24

25. What is EVA pharma main focus? M eeting unmet needs Producing affordable insulin in Africa: In collaboration with Lilly, they completed a new biologics facility to manufacture insulin with the aim of increasing access for patients in Africa. Partnering with large pharmaceutical companies: Collaborations like the one with Roche for organ transplant medication localization demonstrate their dedication to bringing more advanced treatments to emerging markets. Investing in local production facilities: Their recent partnership with MODON to establish an industrial complex in Saudi Arabia is another example of their efforts to localize production and improve medication availability in the region. 25

26. Overview What are the industrial potential of EVA pharma ? EVA Pharma’s dedicated and internationally accredited immunosuppressant manufacturing facility in 10th of Ramadan city Effects of exposure Funding for future research Scientific findings 26

27. Thank you Mina Sami Info. About EVA Provided by EVA pharma website 27